Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03138798 · ClinicalTrials.gov registry record · NA

Dental Support Device in the Second Stage of Labor

A NA study of Labor, sponsored by Angela Bian.

Completed
Registry status
NA
Development phase
348
Enrollment target
1
Study location

NCT03138798: Completed NA study of Labor, sponsored by Angela Bian.

NCT03138798 is a NA study of Labor that has completed, run by Angela Bian. The registered enrollment target is 348 participants, above the 166-participant average among 4 other Labor trials with a reported enrollment target (110% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03138798, a NA study of Labor, has completed, sponsored by Angela Bian.

COMPLETED
Registry status
NA
Development phase
348 participants
Enrollment target
1
Study location

Study Summary

Obstetric practices now allow for prolonged second stage of labor to accomplish vaginal delivery. However, this practice may lead to either operative delivery (vacuum or forceps assisted delivery) or cesarean section with significant maternal/neonatal morbidity. Limited evidence suggests that dental support devices (DSD) may improve lead to shortened labor by allowing patients to push more effectively.

Primary Outcome

At the time of pushing in the second stage of labor, the time from full dilation to delivery during the second stage of labor in patients with vaginal delivery (spontaneous, vacuum, forceps included). Intention to treat analysis.

Conditions Studied

Interventions

  • DEVICE Laboraide TM dental support device

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 348 participants
Start Date 2017-01-06
Est. Completion 2017-11-07
Phase NA
Angela Bian

1 total trials

What the finished NCT03138798 record still lists

NCT03138798 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 4 other Labor trials with a reported enrollment target (110% higher).

The record links to 1 condition, with Labor appearing as the primary indexed condition, and to 1 intervention - of which Laboraide TM dental support device is the first listed.

NCT03138798 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03138798 about?

NCT03138798 is a clinical study titled "Dental Support Device in the Second Stage of Labor". Obstetric practices now allow for prolonged second stage of labor to accomplish vaginal delivery. However, this practice may lead to either operative delivery (vacuum or forceps assisted delivery) or cesarean section with significant maternal/neonatal morbidity. Limited evidence suggests that dental...

What is the current status of trial NCT03138798?

This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2017-01-06. Estimated completion is 2017-11-07.

What conditions does trial NCT03138798 study?

This clinical trial studies the following conditions: Labor.

What interventions are being tested in trial NCT03138798?

The interventions under investigation include: Laboraide TM dental support device (DEVICE).

Who is sponsoring clinical trial NCT03138798?

This trial is sponsored by Angela Bian, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03138798 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04041479 · 348 participants · Phase 3

    Biomarker-guided rTMS for Treatment Resistant Depression

  • NCT04530565 · 348 participants · Phase 3

    Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

  • NCT05428735 · 348 participants · NA

    The DRAGON 2 Trial

  • NCT05787379 · 348 participants · NA

    Care for Veterans Post-COVID-19

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03138798, the US trial registry maintained by the National Library of Medicine. NCT03138798 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.